View in EDS

Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program.

Saved in:
Bibliographic Details
Title: Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program.
Authors: Winkelmayer WC; Section of Nephrology, Baylor College of Medicine, Houston, TX., Burke SK; Akebia Therapeutics Inc, Cambridge, MA., Chertow GM; Stanford University School of Medicine, Stanford, CA., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany., Luo W; Akebia Therapeutics Inc, Cambridge, MA., Minga T; Akebia Therapeutics Inc, Cambridge, MA., Sarnak MJ; Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA., Roy-Chaudhury P; Division of Nephrology and Hypertension, University of North Carolina Kidney Center, NC, and WG (Bill) Hefner VA Medical Center, Salisbury, NC.
Source: Kidney medicine [Kidney Med] 2025 Mar 19; Vol. 7 (5), pp. 100997. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101756300 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0595 (Electronic) Linking ISSN: 25900595 NLM ISO Abbreviation: Kidney Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40330911
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO<subscript>2</subscript>VATE Trial Program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Winkelmayer+WC%22">Winkelmayer WC</searchLink>; Section of Nephrology, Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Burke+SK%22">Burke SK</searchLink>; Akebia Therapeutics Inc, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Chertow+GM%22">Chertow GM</searchLink>; Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Eckardt+KU%22">Eckardt KU</searchLink>; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Luo+W%22">Luo W</searchLink>; Akebia Therapeutics Inc, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Minga+T%22">Minga T</searchLink>; Akebia Therapeutics Inc, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Sarnak+MJ%22">Sarnak MJ</searchLink>; Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Roy-Chaudhury+P%22">Roy-Chaudhury P</searchLink>; Division of Nephrology and Hypertension, University of North Carolina Kidney Center, NC, and WG (Bill) Hefner VA Medical Center, Salisbury, NC.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101756300%22">Kidney medicine</searchLink> [Kidney Med] 2025 Mar 19; Vol. 7 (5), pp. 100997. <i>Date of Electronic Publication: </i>2025 Mar 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101756300 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-0595 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225900595%22">25900595 </searchLink><i>NLM ISO Abbreviation: </i>Kidney Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40330911
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xkme.2025.100997
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100997
    Titles:
      – TitleFull: Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Winkelmayer WC
      – PersonEntity:
          Name:
            NameFull: Burke SK
      – PersonEntity:
          Name:
            NameFull: Chertow GM
      – PersonEntity:
          Name:
            NameFull: Eckardt KU
      – PersonEntity:
          Name:
            NameFull: Luo W
      – PersonEntity:
          Name:
            NameFull: Minga T
      – PersonEntity:
          Name:
            NameFull: Sarnak MJ
      – PersonEntity:
          Name:
            NameFull: Roy-Chaudhury P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 03
              Text: 2025 Mar 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2590-0595
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Kidney medicine
              Type: main
ResultId 1